TMCnet News
Research and Markets: Osteoporosis - Pipeline Review, H1 2014: 60 Companies and 94 Drugs ProfiledDUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/p8lbtw/osteoporosis) has announced the addition of the "Osteoporosis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Osteoporosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Osteoporosis and special features on late-stage and discontinued projects. The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sitesand industry-specific third party sources. Companies Involved:
Drug Profiles:
For more information visit http://www.researchandmarkets.com/research/p8lbtw/osteoporosis
|